Transcript
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 1/34
2. Autoimmunity2. Autoimmunity
or Autoantibodiesor Autoantibodies
Inappropriate reaction by the immune system inInappropriate reaction by the immune system in
which antibodies form against self antigens,which antibodies form against self antigens,
mistaken as foreign.mistaken as foreign.
E.g.E.g.
– Tissue injury ( may help the body rid itself of damagedTissue injury ( may help the body rid itself of damaged
or necrotic self component)or necrotic self component)
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 2/34
Etiology:Etiology:
– Altered antigensAltered antigens
– Cross reactive antibodiesCross reactive antibodies
– Viral factorsViral factors
– Hormonal factorsHormonal factors
– Genetic factorsGenetic factors
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 3/34
PathophysiologyPathophysiology: 3 ways of auto immune response: 3 ways of auto immune response
cause diseasecause disease
The action of antibodies on cell surfacesThe action of antibodies on cell surfaces:: byby
direct antibody-mediated cellular cytotoxicitydirect antibody-mediated cellular cytotoxicity------
interference with receptors --- or complement interference with receptors --- or complement
activation.activation.
The circulation and deposition of small immuneThe circulation and deposition of small immune
complexescomplexes :: soluble antigen-antibody complexessoluble antigen-antibody complexes
– invade and deposit in the capillaries, the– invade and deposit in the capillaries, the
synovium of joints---synovium of joints--- it causes tissue damage viait causes tissue damage via
activation of the complement system.activation of the complement system. Activation of sensitized T lymphocytes Activation of sensitized T lymphocytes: by the: by the
release of lymphokines.release of lymphokines.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 4/34
– InterventionIntervention::
Anti-inflammatory agents – symptomaticAnti-inflammatory agents – symptomatic
relief.relief.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 5/34
Assessment andAssessment and
Management of Patients WithManagement of Patients WithAllergic DisordersAllergic Disorders
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 6/34
Allergic ReactionsAllergic Reactions
AllergyAllergy
– An inappropriate, often harmful response of An inappropriate, often harmful response of
the immune system to normally harmlessthe immune system to normally harmless
substancessubstances
– Hypersensitive reaction to an allergen initiatedHypersensitive reaction to an allergen initiated
by immunological mechanisms that is usuallyby immunological mechanisms that is usually
mediated by IgE antibodiesmediated by IgE antibodies
AllergenAllergen: the substance that causes the allergic: the substance that causes the allergic
responseresponse
Atopy:Atopy: allergic reactions characterized by IgEallergic reactions characterized by IgE
antibody action and a genetic predispositionantibody action and a genetic predisposition
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 7/34
Immunoglobulins and AllergicImmunoglobulins and Allergic
ResponseResponse
AntibodiesAntibodies (IgE, IgD, IgG, IgM, and IgA) react(IgE, IgD, IgG, IgM, and IgA) reactwith specific effector cells and molecules, andwith specific effector cells and molecules, andfunction to protect the bodyfunction to protect the body
IgE antibodiesIgE antibodies are involved in allergic disordersare involved in allergic disorders
IgE moleculesIgE molecules bind to an allergen and triggerbind to an allergen and triggermast cells or basophilsmast cells or basophils
These cells then releaseThese cells then release chemical mediatorschemical mediators suchsuchasas histamine, serotonin, kinins, SRS-A, andhistamine, serotonin, kinins, SRS-A, and
neutrophil factorneutrophil factorThese chemical substances cause the reactionsThese chemical substances cause the reactionsseen in allergic responseseen in allergic response
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 8/34
Immunoglobulins and Allergic ResponseImmunoglobulins and Allergic Response
(cont.)(cont.)
Allergen triggers the B cell to make IgE antibody, whichAllergen triggers the B cell to make IgE antibody, which
attaches to the mast cell; when that allergen reappears, it bindsattaches to the mast cell; when that allergen reappears, it binds
to the IgE and triggers the mast cell to release its chemicalsto the IgE and triggers the mast cell to release its chemicals
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 9/34
HypersensitivityHypersensitivity
A reflection of excessive or aberrantA reflection of excessive or aberrant
immune responseimmune response
Sensitization: initiates the buildup of Sensitization: initiates the buildup of
antibodiesantibodies
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 10/34
Predisposing FactorsPredisposing Factors
Host defensesHost defenses
Nature of the allergenNature of the allergen
Concentration of the allergenConcentration of the allergenRoute of allergen entrance into theRoute of allergen entrance into the
bodybody
Exposure to the allergenExposure to the allergen
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 11/34
Types of hypersensitivity reactionsTypes of hypersensitivity reactions
–Anaphylactic: type IAnaphylactic: type I
–Cytotoxic: type IICytotoxic: type II
–Immune complex: type IIIImmune complex: type III
–Delayed type: type IVDelayed type: type IV
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 12/34
Type I—Anaphylactic ReactionType I—Anaphylactic Reaction
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 13/34
– Type I.Anaphylactic shockType I.Anaphylactic shock
Most severe form of type I hypersensitivityMost severe form of type I hypersensitivityClinical ManifestationsClinical Manifestations::
– ItchingItching
– EdemaEdema
– Sneezing ( wheezing, dyspnea, cyanosis,Sneezing ( wheezing, dyspnea, cyanosis,circulatory shock)circulatory shock)
– ASAP emergency treatmentASAP emergency treatment
Prevention Prevention::
– History: drugs ( antibiotics- penicilllins); FoodsHistory: drugs ( antibiotics- penicilllins); Foods
( seafoods); Insect venoms; Biologicals( seafoods); Insect venoms; Biologicals
( vaccines, hormones, enzymes, antisera); blood( vaccines, hormones, enzymes, antisera); blood
products; allergen extracts; diagnostic agentsproducts; allergen extracts; diagnostic agents
( dye)( dye)
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 14/34
Type II—Cytotoxic ReactionType II—Cytotoxic Reaction
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 15/34
– Type II Cytolytic or CytotoxicType II Cytolytic or Cytotoxic
HypersensitivityHypersensitivity
The antigen-antibody complex and complementThe antigen-antibody complex and complementattach to a cell – circulating blood cellattach to a cell – circulating blood cell cell lysis.cell lysis.
Blood transfusion - blood incompatibilityBlood transfusion - blood incompatibility cell lysiscell lysis
( transfusion reaction – of donor RBC)( transfusion reaction – of donor RBC)
Note: Blood transfusion > 100ml. incompatible –Note: Blood transfusion > 100ml. incompatible –
renal damage, circulatory shock, and death.STOPrenal damage, circulatory shock, and death.STOPTransfusion ASAP.Transfusion ASAP.
Clinical ManifestationsClinical Manifestations::
– Headache and backpainHeadache and backpain
– Chest pain- similar to anginaChest pain- similar to angina
– N& VN& V– Tachycardia and hypotensionTachycardia and hypotension
– HematuriaHematuria
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 16/34
Type III—Immune Complex ReactionType III—Immune Complex Reaction
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 17/34
Type III Immune Complex HypersensitivityType III Immune Complex Hypersensitivity
– From the formation or deposition of From the formation or deposition of
antigen-antibody complexes in tissuesantigen-antibody complexes in tissues– Molecular size – larger – rapidly clearedMolecular size – larger – rapidly cleared
by phagocytic cells.--- smaller persistsby phagocytic cells.--- smaller persists
longer in circulationlonger in circulation spleen and liverspleen and liver
Inflammation -Inflammation - acute or chronicacute or chronicdisease of the organ systemdisease of the organ system
E.g. serum sickness, urticaria,E.g. serum sickness, urticaria,
arthritis, arteritis,arthritis, arteritis,glomerulonephritis.glomerulonephritis.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 18/34
Type IV—Delayed or Cellular Type IV—Delayed or Cellular
ReactionReaction
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 19/34
Type IV Cell Mediated DelayedType IV Cell Mediated DelayedHypersensitivityHypersensitivity
– Sensitized T cells respond to antigens by releasingSensitized T cells respond to antigens by releasinglymphokines, which direct phagocytic cell activity.lymphokines, which direct phagocytic cell activity.
– E.g.E.g.
Delayed hypersensitivity – chronic infection ( TB)Delayed hypersensitivity – chronic infection ( TB)
Graft versus host disease or transplant rejectionGraft versus host disease or transplant rejection
- Contact Dermatitis (48-72)- Contact Dermatitis (48-72)- Granuloma formation- 10-28 days, (leprosy)- Granuloma formation- 10-28 days, (leprosy)
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 20/34
Management of Patients WithManagement of Patients With
Allergic DisordersAllergic Disorders
History and manifestations; comprehensive allergyHistory and manifestations; comprehensive allergyhistory;history;
Diagnostic testsDiagnostic tests
– CBC-eosinophil countCBC-eosinophil count
– Total serum IgETotal serum IgE
– Skin tests: note precautionsSkin tests: note precautions
Screening proceduresScreening procedures
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 21/34
MedicationMedication
Oxygen, if respiratory assistance neededOxygen, if respiratory assistance needed
Epinephrine for anaphylactic reactionsEpinephrine for anaphylactic reactions
AntiHistaminesAntiHistamines
CorticosteroidsCorticosteroids
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 22/34
Prevention and Treatment of AnaphylaxisPrevention and Treatment of Anaphylaxis
Screen and prevent:Screen and prevent:
Treat respiratory problems; provide oxygen,Treat respiratory problems; provide oxygen,intubation, and cardiopulmonary resuscitation asintubation, and cardiopulmonary resuscitation as
neededneeded
Epinephrine: 1:1,000Epinephrine: 1:1,000 SQSQ
Auto injection system: EpiPenAuto injection system: EpiPen
May follow with IV epinephrineMay follow with IV epinephrine
IV fluidsIV fluids
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 23/34
Other Allergic DisordersOther Allergic Disorders
Contact dermatitisContact dermatitis
Atopic dermatitisAtopic dermatitis
Drug reactions (dermatitis medicamentosa)Drug reactions (dermatitis medicamentosa)Urticaria and angioneurotic edemaUrticaria and angioneurotic edema
Food allergyFood allergy
Serum sicknessSerum sickness
Latex allergyLatex allergy
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 24/34
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 25/34
The round or disk shaped (discoid) rash of lupus producesThe round or disk shaped (discoid) rash of lupus produces
red, raised patches with scales. The pores (hair follicles)red, raised patches with scales. The pores (hair follicles)
may be plugged. Scarring often occurs in older lesions. Themay be plugged. Scarring often occurs in older lesions. The
majority (approximately 90%) of individuals with discoidmajority (approximately 90%) of individuals with discoid
lupus have only skin involvement as compared to morelupus have only skin involvement as compared to moregeneralized involvement in systemic lupus erythematosisgeneralized involvement in systemic lupus erythematosis
(SLE).(SLE).
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 26/34
Systemic Lupus Erythematous (SLE)Systemic Lupus Erythematous (SLE)
a chronic inflammatory disease of a chronic inflammatory disease of autoimmune origin.autoimmune origin.
presence of presence of autoantibodiesautoantibodies to numerousto numerousnuclear proteins, blood and nerve cells,nuclear proteins, blood and nerve cells,
and blood proteins.and blood proteins.InflammationInflammation – every organ system.– every organ system.
Lesions:Lesions: connective tissue of the vascularconnective tissue of the vascularsystem, the kidney, the dermis, thesystem, the kidney, the dermis, the
serous, synovial membranes.serous, synovial membranes.Long and chronic, with exacerbations,Long and chronic, with exacerbations,
remissions.remissions.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 27/34
Etiology and IncidenceEtiology and Incidence
SLE is associated with a geneticSLE is associated with a geneticpredisposition to the disease as wellpredisposition to the disease as wellas a family history autoimmuneas a family history autoimmune
disorders.disorders.
It occurs most commonly in women,It occurs most commonly in women,
especially among those ages 20-30;especially among those ages 20-30;incidence is higher among Africanincidence is higher among AfricanAmericans than whitesAmericans than whites
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 28/34
PATHOPHYSIOLOGYPATHOPHYSIOLOGY(process & manifestation)(process & manifestation)
SLE is characterized by the formation of SLE is characterized by the formation of antibodies (IgE and IgM) against theantibodies (IgE and IgM) against thebody’s nucleic acids, phospholipids, whitebody’s nucleic acids, phospholipids, whiteblood cells, red blood cells, andblood cells, red blood cells, and
coagulation components.coagulation components.
Antigen-antibody complexes against hostAntigen-antibody complexes against hostDNA form and deposit in a variety of DNA form and deposit in a variety of
tissues, causing diffuse damage.tissues, causing diffuse damage.
Neutrophils attempt to phagocytize theNeutrophils attempt to phagocytize theantigen-antibody complexes, but areantigen-antibody complexes, but areineffective.ineffective.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 29/34
Lysosomal enzymes are released,Lysosomal enzymes are released,further propagating the tissuefurther propagating the tissue
damage.damage.
The glomerular basement membraneThe glomerular basement membraneof the kidneys is particularlyof the kidneys is particularly
susceptible to complex deposition; assusceptible to complex deposition; asa result, there is a high incidence of a result, there is a high incidence of renal failure secondary to SLE.renal failure secondary to SLE.
Deposition of complex also occurs inDeposition of complex also occurs inthe brain, heart lung, GI tractthe brain, heart lung, GI tract,spleen and skin.,spleen and skin.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 30/34
Clinical ManifestationsClinical Manifestations::
– Joint inflammation ( arthritis)Joint inflammation ( arthritis)– Classic butterfly rash over the cheeks andClassic butterfly rash over the cheeks and
bridge of the nose.bridge of the nose.
– PhotosensitivityPhotosensitivity
– renal, cardiac, and CNS dysfunction.renal, cardiac, and CNS dysfunction.(Raynaud’s Syndrome)(Raynaud’s Syndrome)
– GI symptoms: n&v, esophagitis, anorexiaGI symptoms: n&v, esophagitis, anorexia
Other symptomsOther symptoms::
Wt. loss; fever, malaise; lethargyWt. loss; fever, malaise; lethargy
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 31/34
Laboratory FindingsLaboratory Findings::
– Presence of LE cells ( autoantibodies)Presence of LE cells ( autoantibodies)– Decreased complement levelsDecreased complement levels
– Presence of immune complexes inPresence of immune complexes in
serumserum
– Presence of antibodies to DNA andPresence of antibodies to DNA and
antinuclear antibodies.antinuclear antibodies.
– Decreased levels of rbc, wbc,Decreased levels of rbc, wbc,
plateletsIncreased gamma globulinplateletsIncreased gamma globulinfraction d/t increased antibodyfraction d/t increased antibody
production.production.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 32/34
Nursing DiagnosesNursing Diagnoses::– Impaires physicl mobility d/t arthritis, malaise andImpaires physicl mobility d/t arthritis, malaise and
lethargy.lethargy.
– Alt. in comfort: pain d/t inflammationAlt. in comfort: pain d/t inflammation
– Fluid volume deficit d/t vomitingFluid volume deficit d/t vomiting
– Alt. in nutrition: less than body requirements d/tAlt. in nutrition: less than body requirements d/t
anorexia, nausea, esophagitis.anorexia, nausea, esophagitis.
– Potential for infection d/t poor physical conditionPotential for infection d/t poor physical condition– Grieving d.t chronic nature of SLE and adventGrieving d.t chronic nature of SLE and advent
exacerbationsexacerbations
– Disturbance in self concept: body image d/t butterflyDisturbance in self concept: body image d/t butterfly
rash and alopeciarash and alopecia
– Alt. in tissue perfusion: renal, GI and peripheral d/tAlt. in tissue perfusion: renal, GI and peripheral d/tvasculitis.vasculitis.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 33/34
Pharmacologic and Medical InterventionPharmacologic and Medical Intervention::– NSAID anti inflammatory agents e.g.NSAID anti inflammatory agents e.g.
Salicylates ( Aspirin)Salicylates ( Aspirin)– Anti malarial drugs – cutaneous and jointAnti malarial drugs – cutaneous and jointinflammation.inflammation.
– Corticosteroids – d/t systemic inflammatoryCorticosteroids – d/t systemic inflammatorymanifestations of the disease.manifestations of the disease.
– Cytotoxic agents : alkylating agentsCytotoxic agents : alkylating agents( cyclosphamide), and antifolates( cyclosphamide), and antifolates( methotrexate)( methotrexate)
– Plasmapheresis – remove circulatingPlasmapheresis – remove circulating
autoantibodies and immune complexes fromautoantibodies and immune complexes fromthe blood before organ and tissue damagethe blood before organ and tissue damageoccurs.occurs.
8/14/2019 Alterations in IMMUNO
http://slidepdf.com/reader/full/alterations-in-immuno 34/34
Other InterventionsOther Interventions
Improve airway clearanceImprove airway clearance
– Use semi-Fowler's or high-Fowler’sUse semi-Fowler's or high-Fowler’spositionposition
– Pulmonary therapy; coughing and deepPulmonary therapy; coughing and deepbreathing; postural drainage;breathing; postural drainage;percussion; and vibrationpercussion; and vibration
– Ensure adequate restEnsure adequate rest
PainPain– Administer medications as prescribedAdminister medications as prescribed
– Provide skin and perianal careProvide skin and perianal care
top related